AbbVie Ventures
Overview
AbbVie Ventures is the corporate venture capital arm of AbbVie that invests in novel, transformational therapeutics at discovery and pre-clinical stages . Aligning with AbbVie’s strategic focus, their investments address critical needs in oncology, immunology, neuroscience, eye care, and aesthetics . AbbVie Ventures offers its partners access to AbbVie's vast internal network of experts in all phases of drug development, from drug discovery through successful commercialization .
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Morphic | Sep 2018 | Series B | Co-investor |
| Palleon Pharmaceuticals | Sep 2020 | Series B | Co-investor |
| Cephagenix | Jan 2025 | Seed | Lead |
| Endlyz Therapeutics | Mar 2026 | Seed | Co-investor |
| Accent Therapeutics | Jan 2024 | Series C | Co-investor |
For institutional investors. Book with your work email.
Key People
Mohamad Abubakar
Co-Founder
Alina Köhler
Employee Relations Partner
Busra Polat Kahveci
Learning Partner
Catherine Lamontagne
Manager Learning Partner
Charlie Hallard
Affiliate PV Partner Compliance Specialist
Chris Phillips
Learning Partner (In Field Excellence)
James F Baum
Pharmacy Solutions Partner
Kelly Fatten
Learning Partner
Lynn Gabb
Manager, Affiliate PV Partner Compliance
Mia G.
Data Engineering Bussiness Partner UK Data Lead
Paige Passaro
Learning Partner
Paula Wurm
HR Business Excellence Partner
Rachael Dalton
Learning Partner
Rafael Tonon
Business Insights Partner
Rhonda Sharpe
Learning Partner
Sophie van Bohemen - de Vries
Learning Partner
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is AbbVie Ventures based?
AbbVie Ventures is headquartered in Cambridge, Massachusetts, United States.
When was AbbVie Ventures founded?
AbbVie Ventures was founded in 2009.
How many portfolio companies does AbbVie Ventures have?
AbbVie Ventures has 29 portfolio companies in Caplight's dataset.
What are some companies in AbbVie Ventures's portfolio?
Portfolio companies visible on Caplight include Morphic, Palleon Pharmaceuticals, Cephagenix, Endlyz Therapeutics, Accent Therapeutics.
What was AbbVie Ventures's most recent investment shown here?
AbbVie Ventures's most recent investment in this portfolio sample was in Endlyz Therapeutics in 2026.
What sectors does AbbVie Ventures focus on?
AbbVie Ventures focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure.
What company stages does AbbVie Ventures focus on?
AbbVie Ventures typically invests at the Early stage.
What is AbbVie Ventures's AUM?
AbbVie Ventures's assets under management are estimated between $100.0M and $250.0M.